Seoulin Bioscience Co.,Ltd.
Financials
Valuation Metrics
Seoulin Bioscience Co.,Ltd.'s Market Cap is ₩378B. At end of 2025 it was ₩605B. Ranked #1939 of 2,421 in KR market (top 80%), #1214 of 1,640 on KOSDAQ (top 74%), #205 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 89%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 37.76B KRW | KR#1,939/2,421 Sec#205/231 |
| Revenue | 83.17B KRW | KR#1,527/2,421 Sec#96/231 |
| Net Income | 844.7M KRW | KR#1,492/2,421 Sec#103/231 |
| Total Assets | 115.24B KRW | KR#1,671/2,421 Sec#132/231 |
| Net Assets | 85.63B KRW | KR#1,529/2,421 Sec#122/231 |
| Employees | 110 | KR#1,574/2,421 Sec#123/231 |
| Value | ||
| P/E | 44.70x | KR#1,396/2,421 Sec#89/231 |
| P/B | 0.44x | KR#662/2,421 Sec#23/231 |
| PEG | 0.00x | KR#22/2,421 Sec#1/231 |
| P/S | 0.45x | KR#856/2,421 Sec#36/231 |
| EV/EBITDA | 81.99x | KR#1,457/2,421 Sec#95/231 |
| Profitability | ||
| ROE | 0.99% | KR#1,484/2,421 Sec#102/231 |
| ROA | 0.73% | KR#1,438/2,421 Sec#101/231 |
| Op. Margin | 0.61% | KR#1,546/2,421 Sec#109/231 |
| Revenue Growth | 17.13% | KR#623/2,421 Sec#57/231 |
| Earnings Growth | 40684.69% | KR#1/2,421 Sec#1/231 |
| Financial Health | ||
| Debt Ratio | 34.58% | KR#680/2,421 Sec#79/231 |
| Total Debt | 12.89B KRW | KR#1,543/2,421 Sec#135/231 |
| Cash | 9.32B KRW | KR#1,735/2,421 Sec#148/231 |
| Current Ratio | 2.73x | KR#625/2,421 Sec#82/231 |
| Net Debt/EBITDA | 7.08x | KR#1,129/2,421 Sec#84/231 |
| Dividend | ||
| Div. Yield | 2.41% | KR#771/2,421 Sec#39/231 |
| Div. Growth | 0.00% | KR—/2,421 Sec—/231 |
| Performance | ||
| 1Y Return | -39.29% | KR#1,815/2,421 Sec#151/231 |
| 1M Return | -5.36% | KR#1,823/2,421 Sec#146/231 |
| From 52W High | -47.78% | KR#1,280/2,421 Sec#96/231 |
| 1Y MDD | -40.88% | KR#617/2,421 Sec#42/231 |
| Trading | ||
| Volume | 6,081 shares | KR#2,078/2,421 Sec#199/231 |
| Trading Value | 24.9M KRW | KR#2,090/2,421 Sec#208/231 |
| Foreign Own. | 1.96% | KR#1,647/2,421 Sec#160/231 |
| Per Share | ||
| EPS | 91 KRW | KR#1,436/2,421 Sec#96/231 |
| BPS | 9,207 KRW | KR#1,047/2,421 Sec#71/231 |
Company Info
SEORIN BIO, founded in 1984, converted to a corporation in 1994, and listed on KOSDAQ in 2005, is a specialized bio company. It provides raw and subsidiary materials for biopharmaceuticals and reagents/equipment for basic life science research, offering total solutions across the bio industry with over 58,000 items. The company supplies core raw materials like cell culture media through global partnerships and supports customer R&D with its industry experience and cold chain logistics infrastructure. SEORIN BIO is headquartered in Seongnam-si, Gyeonggi-do.